Compare UDR & GMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UDR | GMED |
|---|---|---|
| Founded | 1972 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.2B | 11.7B |
| IPO Year | N/A | 2012 |
| Metric | UDR | GMED |
|---|---|---|
| Price | $38.09 | $88.09 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 13 | 15 |
| Target Price | $40.46 | ★ $97.15 |
| AVG Volume (30 Days) | ★ 5.7M | 1.1M |
| Earning Date | 02-09-2026 | 02-24-2026 |
| Dividend Yield | ★ 4.57% | N/A |
| EPS Growth | 338.59 | ★ 358.86 |
| EPS | 1.13 | ★ 3.08 |
| Revenue | $1,740,705,000.00 | ★ $2,769,804,000.00 |
| Revenue This Year | $1.40 | $17.97 |
| Revenue Next Year | $3.46 | $8.61 |
| P/E Ratio | $33.74 | ★ $28.61 |
| Revenue Growth | 2.38 | ★ 11.75 |
| 52 Week Low | $32.94 | $51.79 |
| 52 Week High | $46.47 | $101.40 |
| Indicator | UDR | GMED |
|---|---|---|
| Relative Strength Index (RSI) | 54.91 | 45.30 |
| Support Level | $37.82 | $86.07 |
| Resistance Level | $40.17 | $89.64 |
| Average True Range (ATR) | 0.99 | 2.55 |
| MACD | 0.11 | -0.42 |
| Stochastic Oscillator | 47.23 | 26.58 |
UDR Inc is a real estate investment trust that owns, operates, acquires, renovates, develops, redevelops, disposes of, and manages multifamily apartment communities in targeted markets located in the United States. The company has two reportable segments; Same-Store Communities segment represents those communities acquired, developed, and stabilized; and Non-Mature Communities/Other segment represents those communities that do not meet the criteria to be included in Same-Store Communities, including, but not limited to, recently acquired, developed and redeveloped communities, and the non-apartment components of mixed-use properties. It generates key revenue from Same-Store Communities.
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.